Vapotherm, Inc. (NYSE:VAPO) SVP Gregoire Ramade sold 2,000 shares of the company’s stock in a transaction dated Monday, February 22nd. The shares were sold at an average price of $27.91, for a total transaction of $55,820.00.
Gregoire Ramade also recently made the following trade(s):
- On Wednesday, January 20th, Gregoire Ramade sold 2,000 shares of Vapotherm stock. The shares were sold at an average price of $31.92, for a total transaction of $63,840.00.
- On Monday, December 21st, Gregoire Ramade sold 2,000 shares of Vapotherm stock. The shares were sold at an average price of $27.65, for a total transaction of $55,300.00.
VAPO traded down $0.46 during trading hours on Monday, hitting $28.00. 565,566 shares of the company’s stock were exchanged, compared to its average volume of 393,740. The firm has a market cap of $718.51 million, a P/E ratio of -13.51 and a beta of -1.50. Vapotherm, Inc. has a 12-month low of $6.86 and a 12-month high of $54.42. The company has a current ratio of 5.96, a quick ratio of 5.13 and a debt-to-equity ratio of 0.33. The firm has a 50 day moving average of $32.32 and a 200 day moving average of $29.27.
Several large investors have recently bought and sold shares of VAPO. JPMorgan Chase & Co. increased its position in shares of Vapotherm by 19.2% during the fourth quarter. JPMorgan Chase & Co. now owns 8,714 shares of the company’s stock worth $234,000 after acquiring an additional 1,403 shares during the period. Price T Rowe Associates Inc. MD purchased a new position in Vapotherm in the fourth quarter valued at $457,000. Virginia Retirement Systems ET AL grew its stake in Vapotherm by 36.4% during the 4th quarter. Virginia Retirement Systems ET AL now owns 16,500 shares of the company’s stock worth $443,000 after purchasing an additional 4,400 shares in the last quarter. Engineers Gate Manager LP increased its holdings in Vapotherm by 110.9% during the 4th quarter. Engineers Gate Manager LP now owns 21,977 shares of the company’s stock worth $590,000 after purchasing an additional 11,557 shares during the period. Finally, Greenline Partners LLC raised its position in Vapotherm by 20.3% in the 4th quarter. Greenline Partners LLC now owns 9,405 shares of the company’s stock valued at $253,000 after purchasing an additional 1,587 shares in the last quarter. Institutional investors and hedge funds own 70.35% of the company’s stock.
Vapotherm Company Profile
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
Featured Article: Percentage Decliners
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.